AZNO news
Philips Lumify Ultrasound: FDA Early Alert Over Transducer Re-Registration
Unexpected probe re-registration can block scanning until an online step is completed. A separate USB connection issue is also under assessment.
Source announcement:
Official archive photograph: View the Lumify product photo on Philips’ website ↗. Archive product photograph published February 9, 2022; not an image of a reported incident or faulty unit. Linked rather than reproduced here.
US safety communication
What the FDA reported
The FDA’s October 9 early alert describes an unexpected registration problem in Philips Lumify. The Android or iOS app may stop recognising an already registered transducer and request registration again. Scanning is unavailable until that process finishes; completing it needs Wi-Fi or cellular connectivity.
Limited connectivity makes this particularly relevant to pre-hospital settings. Separately, Philips reported that the USB connection between a Lumify transducer and its host phone or tablet may become unstable or disconnect, potentially interrupting scanning.
Manufacturer reports described by FDA
Reported harm: keep the dates and wording clear
By September 29, Philips had reported eight serious injuries and four deaths associated with the issue, according to the FDA. That is the reporting cutoff, not a count newly measured by AZNO on October 17.
This report does not determine causation in individual cases or establish that every Lumify unit will fail.
US scope — check the official identifiers
Which software versions are listed?
The FDA lists the following Lumify software versions. Its linked table provides UDI-DI identifiers; match the actual device and software against the current notice rather than relying on a probe photograph.
iOS: 2.X, 5.0, 5.1.2, 5.1.3.
Android: 1.X, 3.X, 4.X, 5.1, 5.1.1.
Regional instructions — not interchangeable
What the US and UK notices say
US: the FDA advises use where connectivity is readily accessible, with an exception when an immediately available backup ultrasound device is present. It also calls for backup imaging options, circulation of the manufacturer’s letter and a notice near affected units.
UK: NHS Supply Chain’s October 9 notice tells users not to use Lumify outside areas with readily accessible connectivity until the software update is available and installed, and to keep backup devices or modalities available. It also asks organisations to share, display and forward the notice.
These summaries preserve a difference in the published wording. Follow the full, current Philips instructions applicable to your country and equipment; this article is not a substitute for them.
Status in the sources reviewed
Software update and connection assessment
The notices say Philips is developing an update for the registration issue and assessing the USB connection issue. They do not establish that a fix is already available or installed on a particular device.
MedTech Dive reported on October 12 that a Philips spokesperson described a dedicated customer-support taskforce.
Editorial interpretation — not troubleshooting
AZNO note for buyers and technicians
Do not turn a registration prompt into an unsupported diagnosis of a defective transducer, or assume that purchasing a cable resolves the alert. Keep the transducer identifier, host device, OS, app version and exact message together when contacting Philips. The sources reviewed do not provide a diagnostic procedure to distinguish the two reported problems.
For an equipment offer, request written confirmation of the supplied configuration and the status of applicable safety communications. A marketplace listing or this photograph is not evidence that an individual unit has received a corrective action.
Editorial disclosure
AZNO is not issuing this manufacturer action and does not administer it or speak for Philips or the FDA. This is independent informational reporting, not medical advice, regulatory guidance or an offer of a corrective repair.